Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault

被引:63
作者
Bamberger, JD
Waldo, CR
Gerberding, JL
Katz, MH
机构
[1] Univ Calif San Francisco, San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA
[2] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[4] Univ Calif San Francisco, Ctr Aids Prevent Studies, San Francisco, CA 94143 USA
[5] Ctr Dis Control & Prevent, Hosp Infect Program, Atlanta, GA USA
关键词
D O I
10.1016/S0002-9343(99)00018-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the 1998 Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases recommend offering postexposure prophylaxis for human immunodeficiency virus (HN) infection following sexual assault, there are no detailed protocols on how to provide this treatment. Postexposure prophylaxis has been shown to lower the risk of seroconversion following occupational exposure to HIV by 81%, but has not yet been evaluated following sexual exposure. Though scientific data are limited, victims of sexual assault should be given the best information available to make an informed decision regarding postexposure prophylaxis. When the choice is made to take medications to prevent HIV infection, treatment should be initiated as soon as possible, but no later than 72 hours following the assault, and should be continued for 28 days. HIV postexposure prophylaxis should be provided in the context of a comprehensive treatment and counseling program that recognizes the physical and psychosocial trauma experienced by victims of sexual assault. (C) 1999 by Excerpta Medica, Inc.
引用
收藏
页码:323 / 326
页数:4
相关论文
共 22 条
  • [1] ANALYSIS OF A RAPE CASE BY DIRECT SEQUENCING OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 POL AND GAG GENES
    ALBERT, J
    WAHLBERG, J
    LEITNER, T
    ESCANILLA, D
    UHLEN, M
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 5918 - 5924
  • [2] DETECTION OF SEMINAL ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS IN VAGINAL SECRETIONS AFTER SEXUAL INTERCOURSE - POSSIBLE MEANS OF PREVENTING THE RISK OF HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMISSION IN A RAPE VICTIM
    BELEC, L
    MATTA, M
    PAYAN, C
    TEVIBENISSAN, C
    MEILLET, D
    PILLOT, J
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (01) : 113 - 116
  • [3] A case-control study of HIV seroconversion in health care workers after percutaneous exposure
    Cardo, DM
    Culver, DH
    Ciesielski, CA
    Srivastava, PU
    Marcus, R
    Abiteboul, D
    Heptonstall, J
    Ippolito, G
    Lot, F
    McKibben, P
    Bell, DM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (21) : 1485 - 1490
  • [4] Claydon E, 1991, Int J STD AIDS, V2, P200
  • [5] *CTR DIS CONTR PRE, 1998, MMRW, V47, P109
  • [6] Prophylaxis for occupational exposure to HIV
    Gerberding, JL
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (06) : 497 - 501
  • [7] Goodman L.A., 1993, APPLIED PREVENTIVE P, V2, P79, DOI [10.1016/S0962-1849(05)80114-3, DOI 10.1016/S0962-1849(05)80114-3]
  • [8] Anonymous HIV surveillance with risk-factor elicitation: At Perth (for men) and Cornton Vale (for women) Prisons in Scotland
    Gore, SM
    Bird, AG
    Burns, S
    Ross, AJ
    Goldberg, D
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 1997, 8 (03) : 166 - 175
  • [9] HIV TESTING, COUNSELING, AND PROPHYLAXIS AFTER SEXUAL ASSAULT
    GOSTIN, LO
    LAZZARINI, Z
    ALEXANDER, D
    BRANDT, AM
    MAYER, KH
    SILVERMAN, DC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (18): : 1436 - 1444
  • [10] GROTH AN, 1980, AM J PSYCHIAT, V137, P806